Collaborative work between healthcare professionals and commercial life sciences organisations has long been a positive driver for advancements in patient care and progression of innovative medicine.
Takeda’s goal is to reinforce the productive relationship between pharmaceutical companies and healthcare professionals. We support the principles of transparency by disclosing our annual payments in the UK as directed by the EFPIA and local disclosure codes.
Patient Groups – or patient advocacy groups and patient organisations – are important partners for Takeda. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community.
We support patient organisations in our therapeutic areas through sponsorships, grants and donations.
Date of Preparation: March 2021